{"id":"https://openalex.org/W2951809358","doi":"https://doi.org/10.1021/jm00076a011","title":"Synthesis, antiproliferative, and antiviral activity of 4-amino-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d]pyridazin-7(6H)-one and related derivatives","display_name":"Synthesis, antiproliferative, and antiviral activity of 4-amino-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d]pyridazin-7(6H)-one and related derivatives","publication_year":1993,"publication_date":"1993-11-01","ids":{"openalex":"https://openalex.org/W2951809358","doi":"https://doi.org/10.1021/jm00076a011","mag":"2951809358","pmid":"https://pubmed.ncbi.nlm.nih.gov/8254613"},"language":"en","primary_location":{"id":"doi:10.1021/jm00076a011","doi":"https://doi.org/10.1021/jm00076a011","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00076a011","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051066572","display_name":"Eric A. Meade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric A. Meade","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor 48109-1065"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor 48109-1065","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064750495","display_name":"Linda L. Wotring","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda L. Wotring","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110073621","display_name":"John C. Drach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Drach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037842232","display_name":"Leroy B. Townsend","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leroy B. Townsend","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.217,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.75926676,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"36","issue":"24","first_page":"3834","last_page":"3842"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.2605000138282776,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.2605000138282776,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.23770000040531158,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.1809999942779541,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.6819999814033508},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8230000138282776},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.9750000238418579},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.765999972820282},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.8679999709129333},{"id":"https://openalex.org/keywords/halogenated-nucleosides","display_name":"halogenated nucleosides","score":0.593999981880188},{"id":"https://openalex.org/keywords/n-chlorosuccinimide","display_name":"N-chlorosuccinimide","score":0.8090000152587891},{"id":"https://openalex.org/keywords/n-bromosuccinimide","display_name":"N-bromosuccinimide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/n-iodosuccinimide","display_name":"N-iodosuccinimide","score":0.972000002861023}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9118770360946655},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5875518918037415},{"id":"https://openalex.org/C2780814088","wikidata":"https://www.wikidata.org/wiki/Q415872","display_name":"Boron trichloride","level":3,"score":0.5079179406166077},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.491551011800766},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.4550839066505432},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.4211535155773163},{"id":"https://openalex.org/C2776597398","wikidata":"https://www.wikidata.org/wiki/Q5954496","display_name":"Hydrazine (antidepressant)","level":2,"score":0.41145262122154236},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.3250487744808197},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23849323391914368},{"id":"https://openalex.org/C501308230","wikidata":"https://www.wikidata.org/wiki/Q618","display_name":"Boron","level":2,"score":0.12040910124778748},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.09320500493049622},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07698065042495728},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012263","descriptor_name":"Ribonucleosides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D012263","descriptor_name":"Ribonucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018259","descriptor_name":"Herpesvirus 1, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00076a011","doi":"https://doi.org/10.1021/jm00076a011","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00076a011","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:8254613","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8254613","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G168524383","display_name":null,"funder_award_id":"N01-AI 42554","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2549418169","display_name":null,"funder_award_id":"2P30 CA 46592-05","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3608580336","display_name":null,"funder_award_id":"N01 AI72641","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4273480390","display_name":"DRUGS TO TREAT HUMAN CYTOMEGALOVIRUS INFECTIONS","funder_award_id":"n01ai072641-011","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6077714088","display_name":"DEVELOP ANTIVIRAL DRUGS FOR CMV INFECTIONS IN AIDS","funder_award_id":"n01ai042554-001","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000862605","display_name":"University of Michigan Rogel Cancer Center Support Grant 2023-2028","funder_award_id":"P30CA046592","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2002018025","https://openalex.org/W2952855503","https://openalex.org/W2091220577","https://openalex.org/W2952946014","https://openalex.org/W2949874283","https://openalex.org/W2949598004","https://openalex.org/W2950550346","https://openalex.org/W1988038054","https://openalex.org/W2089474886","https://openalex.org/W2808907810"],"abstract_inverted_index":{"The":[0,17,74,126,148],"synthesis":[1],"of":[2,9,21,29,49,57,66,77,130,151],"4-amino-1-beta-D-ribofuranosylpyrrolo[2,3-d]pyridazin-7":[3],"(6H)-one":[4],"(3)":[5],"from":[6,179],"the":[7,58,78,97,117],"reaction":[8],"ethyl":[10],"3-cyano-1-beta-D-ribofuranosylpyrrole-2-carboxylate":[11],"(10)":[12],"and":[13,87,102,132,145,159,169],"hydrazine":[14],"is":[15],"described.":[16],"5:6":[18],"pyrrolo[2,3-d]pyridazin-7(6H)-one":[19],"structure":[20],"3":[22,30,67,137],"was":[23,80,138,175],"established":[24],"via":[25,44],"a":[26,55],"three-step":[27],"conversion":[28],"into":[31],"1-beta-D-ribofuranosylpyrrolo[2,3-d]pyridazin-4,7(5H,6H)-":[32],"dio":[33],"ne":[34],"(14).":[35],"4-Amino-3-chloro-1-beta-D-ribofuranosylpyrrolo[2,3-d]pyridazin+":[36],"++-7(6H)-one":[37],"(16)":[38],"4-amino-3-bromo-1-beta-D-ribofuranosylpyrrolo[2,3-d]pyridazin++":[39],"+-7(6H)-one":[40],"(18)":[41],"were":[42,161],"prepared":[43],"N-chlorosuccinimide":[45],"or":[46],"N-bromosuccinimide":[47],"treatment":[48,65],"4-amino-1-(2,3,5-tri-O-benzyl-beta-":[50],"D-ribofuranosyl)pyrrolo[2,3-d]pyridazin-7(6H)-one":[51],"(7)":[52],"followed":[53],"by":[54],"removal":[56],"benzyl":[59],"groups":[60],"with":[61,68],"boron":[62],"trichloride.":[63],"Direct":[64],"N-iodosuccinimide":[69],"furnished":[70],"4-amino-3-iodo-1-beta-D-ribofuranosylpyrrolo[2,3-d]pyridazin":[71],"-7(6H)-one":[72],"(19).":[73],"antiproliferative":[75,128],"activity":[76,129,174],"compounds":[79,99,153,156],"determined":[81],"in":[82,114,134,140,166,181],"L1210,":[83],"H.":[84,141],"Ep.":[85,142],"2":[86,143],"several":[88],"additional":[89],"human":[90,164,182],"tumor":[91],"cell":[92,183],"lines.":[93,184],"In":[94],"L1210":[95],"cells,":[96],"3-halo-substituted":[98],"16,":[100,157],"18,":[101,158],"19":[103,133,160],"exhibited":[104],"significant":[105],"cytotoxicity":[106,180],"(IC50":[107],"=":[108],"0.2,":[109],"0.1,":[110],"0.08":[111],"microM,":[112],"respectively),":[113],"contrast":[115,135],"to":[116,136],"3-unsubstituted":[118],"compound":[119],"3,":[120],"which":[121],"had":[122],"only":[123,176],"slight":[124],"activity.":[125],"greater":[127],"18":[131],"confirmed":[139],"cells":[144],"KB":[146],"cells.":[147],"antiviral":[149],"evaluation":[150],"these":[152],"revealed":[154],"that":[155],"active":[162],"against":[163],"cytomegalovirus":[165],"both":[167],"plaque-":[168],"yield-reduction":[170],"assays.":[171],"However,":[172],"this":[173],"partially":[177],"separated":[178]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-06-27T00:00:00"}